ANDROGEN REPLACEMENT THERAPY MARKET ANALYSIS

Androgen Replacement Therapy Market, By Product Type (Testosterone Creams/Gels, Testosterone Patches, Testosterone Injections, Testosterone Implants, and Testosterone Tablets/Capsules/Gums), By Active Ingredient (Testosterone, Methyl Testosterone, Testosterone Undecanoate, Testosterone Enanthate, and Testosterone Cypionate), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) -

Published In : Jun 2023
Code : CMI3787
Pages :191
Formats :
Excel and PDF
Industry : Pharmaceutical

Regional Analysis

Global Androgen Replacement Therapy Market- Regional Analysis

Among regions, North America is estimated to hold a dominant position in the global androgen replacement therapy market over the forecast period. This is due to the increasing number of product launches in the region. For instance, on March 2022, the U.S. Food And Drug Administration (FDA) approved testosterone undecanoate capsules called (Tlando), an oral testosterone replacement therapy in the U.S. hypogonadism market. The approval was given to Antares Pharma, a U.S-based specialty pharmaceutical company.

Geographies covered:

North America: U.S. and Canada
Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
Middle East: GCC, Israel, and Rest of Middle East
Africa: South Africa, North Africa, and Central Africa